Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference105 articles.
1. Roles for growth factors in cancer progression;Witsch;Physiology (Bethesda),2010
2. The ErbB signaling network: receptor heterodimerization in development and cancer;Olayioye;Embo J,2000
3. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001
4. ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface;Berger;FEBS Lett,2004
5. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3;Jura;Proc Natl Acad Sci U S A,2009
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment;Journal of Drug Delivery Science and Technology;2024-05
2. Conformational diversity and protein–protein interfaces in drug repurposing in Ras signaling pathway;Scientific Reports;2024-01-12
3. A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer;Journal of Cancer;2024
4. Efficient Convolution Network to Assist Breast Cancer Diagnosis and Target Therapy;Cancers;2023-08-06
5. Conformational diversity and protein-protein interface clusters help drug repurposing in Ras/Raf/MEK/ERK signaling pathway;2023-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3